Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lei You

Showing results (221-230 of 290) with videos related to

Pageof 29
Sort By:
Oncotarget|May 26, 2016
Plasma microRNA panels to diagnose pancreatic cancer: Results from a multicenter studyZhe Cao, Chang Liu, Jianwei Xu, et al.
Environment International|April 29, 2026
Metabolome-wide association study to decipher the risk of exogenous chemical exposure to liver cancer in a Chinese nested case-control cohortChengnan Fang, Pengwei Guan, Huan Yang, et al.
Cancer Letters|February 4, 2024
Crosstalk between metabolic remodeling and epigenetic reprogramming: A new perspective on pancreatic cancerJie Ren, Bo Ren, Xiaohong Liu, et al.
Cancer Letters|May 20, 2020
Mechanistic target of rapamycin in the tumor microenvironment and its potential as a therapeutic target for pancreatic cancerYueze Liu, Mengyu Feng, Hao Chen, et al.
Molecular Cancer|December 2, 2019
Role of the microbiome in occurrence, development and treatment of pancreatic cancerYicheng Wang, Gang Yang, Lei You, et al.
Annals of Surgery|June 27, 2015
Plasma miRNAs Effectively Distinguish Patients With Pancreatic Cancer From Controls: A Multicenter StudyJianwei Xu, Zhe Cao, Wenjing Liu, et al.
Journal of Integrative Plant Biology|October 20, 2022
IQ67 DOMAIN protein 21 is critical for indentation formation in pavement cell morphogenesisXinhua Feng, Shujuan Pan, Haifu Tu, et al.
Bioorganic & Medicinal Chemistry Letters|April 12, 2011
Synthesis and evaluation of quinoxaline derivatives as potential influenza NS1A protein inhibitorsLei You, Eun Jeong Cho, John Leavitt, et al.
Pathology Oncology Research : POR|July 23, 2015
Expression and Significances of MTSS1 in Pancreatic CancerLi Zhou, Jian Li, Qian-Qian Shao, et al.
Cell Death Discovery|March 3, 2025
Enhancer reprogramming: critical roles in cancer and promising therapeutic strategiesJinshou Yang, Feihan Zhou, Xiyuan Luo, et al.
Pageof 29

Showing results (221-230 of 290) with videos related to

Sort By:
Pageof 29
Oncotarget|May 26, 2016
Plasma microRNA panels to diagnose pancreatic cancer: Results from a multicenter studyZhe Cao, Chang Liu, Jianwei Xu, et al.
Environment International|April 29, 2026
Metabolome-wide association study to decipher the risk of exogenous chemical exposure to liver cancer in a Chinese nested case-control cohortChengnan Fang, Pengwei Guan, Huan Yang, et al.
Cancer Letters|February 4, 2024
Crosstalk between metabolic remodeling and epigenetic reprogramming: A new perspective on pancreatic cancerJie Ren, Bo Ren, Xiaohong Liu, et al.
Cancer Letters|May 20, 2020
Mechanistic target of rapamycin in the tumor microenvironment and its potential as a therapeutic target for pancreatic cancerYueze Liu, Mengyu Feng, Hao Chen, et al.
Molecular Cancer|December 2, 2019
Role of the microbiome in occurrence, development and treatment of pancreatic cancerYicheng Wang, Gang Yang, Lei You, et al.
Annals of Surgery|June 27, 2015
Plasma miRNAs Effectively Distinguish Patients With Pancreatic Cancer From Controls: A Multicenter StudyJianwei Xu, Zhe Cao, Wenjing Liu, et al.
Journal of Integrative Plant Biology|October 20, 2022
IQ67 DOMAIN protein 21 is critical for indentation formation in pavement cell morphogenesisXinhua Feng, Shujuan Pan, Haifu Tu, et al.
Bioorganic & Medicinal Chemistry Letters|April 12, 2011
Synthesis and evaluation of quinoxaline derivatives as potential influenza NS1A protein inhibitorsLei You, Eun Jeong Cho, John Leavitt, et al.
Pathology Oncology Research : POR|July 23, 2015
Expression and Significances of MTSS1 in Pancreatic CancerLi Zhou, Jian Li, Qian-Qian Shao, et al.
Cell Death Discovery|March 3, 2025
Enhancer reprogramming: critical roles in cancer and promising therapeutic strategiesJinshou Yang, Feihan Zhou, Xiyuan Luo, et al.
Pageof 29